The ketogenic diet corrects metabolic hypogonadism and preserves pancreatic ß-cell function in overweight/obese men: a single-arm uncontrolled study
Open accessAbstract
BACKGROUND: Overweight and obesity are increasingly spread in our society. Low testosterone levels are often present in these patients, the so-called metabolic hypogonadism, that further alters the metabolic balance in a sort of vicious cycle. Very low-calorie ketogenic diet (VLCKD) has been reported to efficiently reduce body weight, glycaemia, and the serum levels of insulin, glycated hemoglobin, but its effects on β-cell function and total testosterone (TT) levels are less clear. AIM: To evaluate the effects of VLCKD on markers suggested to be predictive of β-cell dysfunction development, such as proinsulin or proinsulin/insulin ratio, and on TT values in a cohort of overweight or obese nondiabetic male patients with metabolic hypogonadism. METHODS: Patients with overweight or obesity and metabolic hypogonadism underwent to VLCKD for 12 weeks. Anthropometric parameters, blood testing for the measurement of glycaemia, insulin, C-peptide, proinsulin, TT, calculation of body-mass index (BMI), and HOMA index were performed before VLCKD and after 12 weeks. RESULTS: Twenty patients (mean age 49.3 ± 5.2 years) were enrolled. At enrollement all patients presented increased insulin, HOMA index, C-peptide, and proinsulin levels, whereas the proinsulin/insulin ratio was within the normal values. After VLCKD treatment, body weight and BMI significantly decreased, and 14.9 ± 3.9% loss of the initial body weight was achieved. Glycaemia, insulin, HOMA index, C-peptide, and proinsulin significantly decreased compared to pre-VLCKD levels. Serum glycaemia, insulin, C-peptide, and proinsulin levels returned within the normal range in all patients. No difference in the proinsulin/insulin ratio was observed after VLCKD treatment. A mean increase of 218.1 ± 53.9% in serum TT levels was achieved and none of the patients showed TT values falling in the hypogonadal range at the end of the VLCKD treatment. CONCLUSIONS: This is the first study that evaluated the effects of VLCKD on proinsulin, proinsulin/insulin ratio, and TT levels. VLCKD could be safely used to improve β-cell secretory function and insulin-sensitivity, and to rescue overweight and obese patients from β-cell failure and metabolic hypogonadism.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A small study in 20 patients with overweight or obesity and functional hypogonadism showed that a very low-calorie ketogenic diet during 12 weeks resulted in a mean increase in total testosterone levels of around 218% (±53.9%).
“A small study in 20 patients with overweight or obesity and functional hypogonadism showed that a very low-calorie ketogenic diet during 12 weeks resulted in a mean increase in total testosterone levels of around 218% (± 53.9%) [24].”
From Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy (2020) · cites this paper as [24]
Several studies with a very low-calorie ketogenic diet showed a positive effect of this diet on body mass index, glycemic control and insulin resistance.
“Several studies with a very low-calorie ketogenic diet showed a positive effect of this diet on body mass index, glycemic control and insulin resistance.”
From Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy (2020) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Chooi, Y. C., Ding, C., & Magkos, F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.09.005 · Cited by 2,849 · cited 1× · see citing works
“They represent two widely spread conditions, whose prevalence doubled since the 1980s, currently affecting one-third of the global population [1].”
BackgroundTestosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736 · see citing works
Benefits and Risks of Bariatric Surgery in Adults: A Review
Arterburn, D. E., Telem, D. A., Kushner, R. F., & Courcoulas, A. P. (2020) · JAMA · doi:10.1001/jama.2020.12567 · Cited by 1,251 · cited 1× · see citing works
“Bariatric surgery seems to have positive results in severely obese patients with or without comorbidity [7] and appears to reverse both hypogonadism [8] and metabolic abnormalities [9].”
BackgroundThe Definition and Prevalence of Obesity and Metabolic Syndrome.
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_1 · Cited by 978 · see citing works
Bueno, N. B., de Melo, I. S. V., de Oliveira, S. L., & da Rocha Ataide, T. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513000548 · Cited by 778 · cited 2× · see citing works
“difference was found for glucose, insulin, and HbA1c levels [18].”
BackgroundTestosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 586 · see citing works
Steven, S., Hollingsworth, K. G., Al-Mrabeh, A., Avery, L., Aribisala, B., Caslake, M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc15-1942 · Cited by 418 · see citing works
Corona, G., Rastrelli, G., Monami, M., Saad, F., Luconi, M., Lucchese, M., Facchiano, E., Sforza, A., Forti, G., Mannucci, E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0955 · Cited by 414 · see citing works
Jørgensen, N. B., Jacobsen, S. H., Dirksen, C., Bojsen-Møller, K. N., Naver, L., Hvolris, L., Clausen, T. R., Wulff, B. S., Worm, D., Lindqvist Hansen, D., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00073.2012 · Cited by 313 · see citing works
Caprio, M., Infante, M., Moriconi, E., Armani, A., Fabbri, A., Mantovani, G., Mariani, S., Lubrano, C., Poggiogalle, E., Migliaccio, S., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01061-2 · Cited by 283 · cited 3× · see citing works
“despite VLCKD has been suggested for the treatment of metabolic hypogonadism [11], according to the authors’”
BackgroundMethodInfluentialSelf-citationNiskanen, L., Laaksonen, D. E., Punnonen, K., Mustajoki, P., Kaukua, J., & Rissanen, A. (2004) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00335.x · Cited by 275 · see citing works
Goday, A., Bellido, D., Sajoux, I., Crujeiras, A. B., Burguera, B., García-Luna, P. P., Oleaga, A., Moreno, B., & Casanueva, F. F. (2016) · Nutrition & Diabetes · doi:10.1038/nutd.2016.36 · Cited by 258 · see citing works
Castellana, M., Conte, E., Cignarelli, A., Perrini, S., Giustina, A., Giovanella, L., Giorgino, F., & Trimboli, P. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09514-y · Cited by 249 · see citing works
Sex Hormones and Sexual Function in Obese Men Losing Weight
Kaukua, J., Pekkarinen, T., Sane, T., & Mustajoki, P. (2003) · Obesity Research · doi:10.1038/oby.2003.98 · Cited by 212 · see citing works
Protein Sparing Therapy during Periods of Starvation with Sepsis or Trauma
Blackburn, C., Flatt, J., Clowes, G. H. A., O'Donnell, T. F., & Hensle, T. (1973) · Annals of Surgery · doi:10.1097/00000658-197305000-00012 · Cited by 210 · see citing works
Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies
Corona, G., Rastrelli, G., Pasquale, G. D., Sforza, A., Mannucci, E., & Maggi, M. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.06.012 · Cited by 169 · see citing works
Hypogonadism and male obesity: Focus on unresolved questions
Grossmann, M. (2018) · Clinical Endocrinology · doi:10.1111/cen.13723 · Cited by 164 · see citing works
Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
Pfützner, A., Kunt, T., Hohberg, C., Mondok, A., Pahler, S., Konrad, T., Lübben, G., & Forst, T. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.682 · Cited by 162 · see citing works
Galloway, J., Hooper, S. A., Spradlin, C., Howey, D., Frank, B. H., Bowsher, R., & Anderson, J. (1992) · Diabetes Care · doi:10.2337/diacare.15.5.666 · Cited by 161 · see citing works
Bistrian, B. R., Blackburn, G. L., Flatt, J.-P., Sizer, J., Scrimshaw, N. S., & Sherman, M. (1976) · Diabetes · doi:10.2337/diab.25.6.494 · Cited by 149 · see citing works
Ng Tang Fui, M., Prendergast, L. A., Dupuis, P., Raval, M., Strauss, B. J., Zajac, J. D., & Grossmann, M. (2016) · BMC Medicine · doi:10.1186/s12916-016-0700-9 · Cited by 124 · see citing works
Nijpels, G., Popp‐Snijders, C., Kostense, P. J., Bouter, L. M., & Heine, R. J. (1996) · Diabetologia · doi:10.1007/bf00400421 · Cited by 120 · see citing works
Safety and tolerability of new-generation anti-obesity medications: a narrative review
Patel, D. K., & Stanford, F. C. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1435129 · Cited by 116 · cited 1× · see citing works
“Several therapeutic approaches have been developed to face up overweight and obesity, such as diet or weight-loss medications, although with documented poor efficacy, side effects, and restricted indications [6].”
BackgroundInsulin, intact and split proinsulin, and coronary artery disease in young men.
Båvenholm, P., Proudler, A., Tornvall, P., Godsland, I., Landou, C., de Faire, U., & Hamsten, A. (1995) · Circulation · doi:10.1161/01.cir.92.6.1422 · Cited by 109 · see citing works
Partsalaki, Karvela, A., & Spiliotis, B. E. (2012) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0131 · Cited by 107 · see citing works
Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis
van Hulsteijn, L. T., Pasquali, R., Casanueva, F., Haluzik, M., Ledoux, S., Monteiro, M. P., Salvador, J., Santini, F., Toplak, H., & Dekkers, O. M. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0666 · Cited by 103 · see citing works
Clinical use of a protein-sparing modified fast.
Bistrian, B. (1978) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.1978.03290210081040 · Cited by 102 · see citing works
Cannarella, R., Condorelli, R. A., Mongioì, L. M., Barbagallo, F., Calogero, A. E., & La Vignera, S. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1615057 · Cited by 91 · see citing works
Self-citationEmerging role of testosterone in pancreatic β cell function and insulin secretion
Xu, W., Morford, J. J., & Mauvais‐Jarvis, F. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0573 · Cited by 86 · cited 1× · see citing works
“Vice versa, low testosterone levels can promote adipocyte proliferation [4] and influence the pancreatic β-cell function [5].”
BackgroundPalgi, A., Read, J., Greenberg, I., Hoefer, M., Bistrian, B., & Blackburn, G. (1985) · American Journal of Public Health · doi:10.2105/ajph.75.10.1190 · Cited by 84 · see citing works
Zethelius, B., Byberg, L., Hales, C. N., Lithell, H., & Berne, C. (2003) · Diabetologia · doi:10.1007/s00125-002-0995-2 · Cited by 68 · see citing works
Role of Intact Proinsulin in Diagnosis and Treatment of Type 2 Diabetes Mellitus
Pfützner, A., Pfützner, A., Larbig, M., & Forst, T. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504774198124 · Cited by 66 · see citing works
Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient.
Capstick, F., Brooks, B., Burns, C., Zilkens, R., Steinbeck, K., & Yue, D. K. (1997) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(97)00038-7 · Cited by 65 · see citing works
Very-low-energy diet for type 2 diabetes: An underutilized therapy?
Rothberg, A. E., McEwen, L. N., Kraftson, A. T., Fowler, C. E., & Herman, W. H. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.014 · Cited by 59 · see citing works
Sarchielli, E., Comeglio, P., Squecco, R., Ballerini, L., Mello, T., Guarnieri, G., Idrizaj, E., Mazzanti, B., Vignozzi, L., Gallina, P., et al. (2016) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2016-2115 · Cited by 56 · cited 1× · see citing works
“dent attenuation of luteinizing hormone (LH) pulses [2]”
BackgroundVangipurapu, J., Stančáková, A., Kuulasmaa, T., Kuusisto, J., & Laakso, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124028 · Cited by 46 · see citing works
Svendsen, P. F., Jensen, F. K., Holst, J. J., Haugaard, S. B., Nilas, L., & Madsbad, S. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2012.691542 · Cited by 46 · see citing works
Pelusi, C., Giagulli, V. A., Baccini, M., Fanelli, F., Mezzullo, M., Fazzini, A., Bianchi, N., Carbone, M. D., De Pergola, G., Mastroroberto, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183369 · Cited by 45 · see citing works
Yudkin, J., Denver, A., Mohamed-ali, V., Ramaiya, K., Nagi, D., Goubet, S., Mclarty, D., & Swai, A. (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1093 · Cited by 43 · see citing works
Are Insulin and Proinsulin Independent Risk Markers for Premature Coronary Artery Disease?
Katz, R., Ratner, R., Cohen, R. M., Eisenhower, E., & Verme, D. (1996) · Diabetes · doi:10.2337/diab.45.6.736 · Cited by 43 · see citing works
Barbosa-Desongles, A., Hernández, C., Simó, R., & Selva, D. (2013) · American Journal of Physiology - Cell Physiology · doi:10.1152/ajpcell.00019.2013 · Cited by 42 · see citing works
Beneficial Effects of an 8-Week, Very Low Carbohydrate Diet Intervention on Obese Subjects
Gu, Y., Yu, H., Li, Y., Ma, X., Lu, J., Yu, W., Xiao, Y., Bao, Y., & Jia, W. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/760804 · Cited by 34 · see citing works
Seftel, A. (2020) · Journal of Urology · doi:10.1097/ju.0000000000001106.02 · Cited by 19
von Berghes, C., Brabant, G. E., Biebermann, H., Krude, H., & Wiegand, S. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00734.x · Cited by 17 · see citing works
Ohkura, T., Inoue, K., Fujioka, Y., Nakanishi, R., Shiochi, H., Sumi, K., Yamamoto, N., Matsuzawa, K., Izawa, S., Ohkura, H., et al. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-453 · Cited by 14 · see citing works
Shabrawy, A. M. E., Elbana, K. A., & Abdelsalam, N. M. (2019) · Diabetes & metabolic syndrome · doi:10.1016/j.dsx.2019.04.044 · Cited by 13 · see citing works
Doulamis, I. P., Tzani, A. I., Konstantopoulos, P. S., Daskalopoulou, A., Spinos, T., Bletsa, E., Mitsopoulou, D., Spinou, Μ., Brinia, M. E., Palaiopanos, K., et al. (2019) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2018-0118 · Cited by 11 · cited 11× · see citing works
“In a case-control study on 50 patients with T2DM and diabetic nephropathy, the value of 0.1145 has been suggested to predict insulinresistance with relatively high sensitivity (92.3”
BackgroundInfluentialBolinder, J., Fernlund, P., Borg, H., Arnqvist, H., Björk, E., Blohmé, G., Eriksson, J. W., Nyström, L., Ostman, J., & Sundkvist, G. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510500261869 · Cited by 10 · see citing works
The protein-sparing modified fast for obesity-related medical problems.
Walters, J. K., Hoogwerf, B., & Reddy, S. (1997) · Cleveland Clinic journal of medicine · doi:10.3949/ccjm.64.5.242 · Cited by 8 · see citing works
Proinsulin/insulin ratio as a predictor of insulin resistance in patients with diabetic nephropathy.
Elmessallamy, F., El-Ashmawy, H. M., Shabrawy, A. M. E., & Radwan, S. (2019) · Diabetes & metabolic syndrome · doi:10.1016/j.dsx.2019.04.036 · Cited by 7 · see citing works
Flagged first, then by citations
3 of the 53 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- [10]Wilder RM The effects of ketonemia on the course of epilepsy Mayo. Clin. Proc. 1921 2 307 308
- [13]Nagy R Dr. Atkins’ diet revolution: a review. Va Med. Mon. 1974 101 5 383 385 4826189
- [24]von Berghes C Brabant G Biebermann H Krude H Wiegand S Proinsulin and the proinsulin/insulin ratio in overweight and obese children and adolescents: relation to clinical parameters, insulin resistance, and impaired glucose regulation Pediatr. Diabetes 2011 12 3 Pt 2 242 249 10.1111/j.1399-5448.2010.00734.x 21518412 · DOI
- [33]Pfützner A Kann PH Pfützner AH Kunt T Larbig M Weber MM Forst T Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance Clin. Lab. 2004 50 9-10 567 573 15481632
Cited by
Sorted by citations
Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism
Genchi, V. A., Rossi, E., Lauriola, C., D’Oria, R., Palma, G., Borrelli, A., Caccioppoli, C., Giorgino, F., & Cignarelli, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158194 · Cited by 140 · see citing works
Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
Ide, V., Vanderschueren, D., & Antonio, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010021 · Cited by 101 · see citing works
“This leads to the synthesis of ketones which have an anorexigenic effect [23,24].”
BackgroundMolecular Mechanisms Underlying the Relationship between Obesity and Male Infertility
Barbagallo, F., Condorelli, R. A., Mongioì, L. M., Cannarella, R., Cimino, L., Magagnini, M. C., Crafa, A., Vignera, S. L., & Calogero, A. E. (2021) · Metabolites · doi:10.3390/metabo11120840 · Cited by 117 · see citing works
Self-citationDi Rosa, C., Lattanzi, G., Spiezia, C., Imperia, E., Piccirilli, S., Beato, I., Gaspa, G., Micheli, V., De Joannon, F., Vallecorsa, N., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192013040 · Cited by 47 · see citing works
New perspectives in functional hypogonadotropic hypogonadism: beyond late onset hypogonadism
Spaziani, M., Carlomagno, F., Tarantino, C., Angelini, F., Vincenzi, L., & Gianfrilli, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1184530 · Cited by 34 · see citing works
“In particular, the effects of the very low-calorie ketogenic diet seem promising to improve insulin-resistance and b-cell dysfunction, thus ameliorating testosterone levels and gonadal function, as described in novel studies (64, 65).”
BackgroundObesity: A Doorway to a Molecular Path Leading to Infertility
Ahmad, R., & Haque, M. (2022) · Cureus · doi:10.7759/cureus.30770 · Cited by 27 · see citing works
Furini, C., Spaggiari, G., Simoni, M., Greco, C., & Santi, D. (2022) · Endocrine · doi:10.1007/s12020-022-03195-5 · Cited by 30 · see citing works
Obesity and Male Reproduction: Do Sirtuins Play a Role?
Barbagallo, F., Vignera, S. L., Cannarella, R., Mongioì, L. M., Garofalo, V., Leanza, C., Marino, M., Calogero, A. E., & Condorelli, R. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020973 · Cited by 25 · see citing works
“Very recently, VLCKD has been shown to be efficacious in the treatment of metabolic hypogonadism in overweight/obese patients [31,108,109].”
BackgroundInfluentialSelf-citationImpact of COVID-19 on testicular function: a systematic review and meta-analysis
Cannarella, R., Marino, M., Crafa, A., Bagnara, V., Vignera, S. L., Condorelli, R. A., & Calogero, A. E. (2024) · Endocrine · doi:10.1007/s12020-024-03705-7 · Cited by 25 · see citing works
Self-citationVery low‐calorie ketogenic diet rapidly augments testosterone levels in non‐diabetic obese subjects
Cignarelli, A., Santi, D., Genchi, V. A., Conte, E., Giordano, F., Di Leo, S., Natalicchio, A., Laviola, L., Giorgino, F., & Perrini, S. (2023) · Andrology · doi:10.1111/andr.13357 · Cited by 19 · see citing works
Balestra, F., Luca, M. D., Panzetta, G., Palieri, R., Shahini, E., Giannelli, G., Pergola, G. D., & Scavo, M. P. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00622-2 · Cited by 15 · see citing works
Erectile Dysfunction in Diabetic Patients: From Etiology to Management
Cannarella, R., Barbagallo, F., Condorelli, R., Gusmano, C., Crafa, A., Vignera, S. L., & Calogero, A. (2021) · Diabetology · doi:10.3390/diabetology2030014 · Cited by 14 · see citing works
Self-citationCannarella, R., Rubulotta, M., Cannarella, V., Vignera, S. L., & Calogero, A. E. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.06.010 · Cited by 13 · see citing works
Self-citationAdvances in the treatment of functional male hypogonadism
Corona, G., Rastrelli, G., Sparano, C., Vignozzi, L., Sforza, A., & Maggi, M. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2296022 · Cited by 18 · see citing works
Yao, T., Song, C., Yu, Y.-J., Cheng, Y., Lu, H.-Y., Li, J., Yang, Y., Tang, D.-H., & Yi, X. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.896735 · Cited by 11 · see citing works
Ken‐Dror, G., Fluck, D. S., Fry, C. H., & Han, T. S. (2023) · Andrology · doi:10.1111/andr.13484 · Cited by 13 · see citing works
“35,36 , The results of leave-one-out sensitivity analyses (Tables S1 and S2) showedthatchangesinTTinducedbyweightlossinobesemenbothin cohortstudiesandinRCTswerenotsubstantiallydrivenbyanyindivid-ual study.”
BackgroundCondorelli, R., Aversa, A., Basile, L., Cannarella, R., Mongioì, L., Cimino, L., Perelli, S., Caprio, M., Cimino, S., Calogero, A., et al. (2022) · Nutrients · doi:10.3390/nu14051081 · Cited by 7 · see citing works
Self-citationSayda, M. H., Aziz, M. H. A., Gharahdaghi, N., Wilkinson, D. J., Greenhaff, P. L., Phillips, B. E., Smith, K., IDRIS, I. R., & Atherton, P. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-21814-z · Cited by 7 · see citing works
Чернова, М. О., Rozhivanov, R. V., Романовна, Р. Е., & Esaulenko, D. I. (2024) · Bulletin of Reproductive Health · doi:10.14341/brh12711 · Cited by 2 · see citing works
The Effects of Different Types of Diets on Steroid Hormone Concentrations
Dušková, M. (2023) · Physiological Research · doi:10.33549/physiolres.935209 · Cited by 3 · see citing works
Male obesity secondary hypogonadism: effectiveness of ketogenic diet on testicular function
Izzo, G., Iuliano, C., Molettieri, P., & Vitale, M. (2023) · Exploration of Foods and Foodomics · doi:10.37349/eff.2023.00014 · Cited by 1 · see citing works
The forgotten confounding variable of the very-low-caloric intervention in the ketogenic diet
Abrahim, M. (2021) · Endocrine · doi:10.1007/s12020-021-02638-9 · Cited by 1 · see citing works
Ketogenic Diet in Obesity and Diabetes: A Narrative Review
An, Y.-S., Norris, N., Li, D.-L., & Gunton, J. (2026) · Nutrients · doi:10.3390/nu18122004
“Indeed, proinsulin levels increase when β -cells are under stress or when secretory pressure is excessive [75].”
The effect of bariatric surgery on testosterone production in men
Rozhivanov, R., Chernova, M. O., Morozova, E. V., Rozhivanova, E. R., Gaidaichuk, K. E., Andreeva, E. N., Mel'nichenko, G., & Mokrysheva, N. (2026) · Obesity and Metabolism · doi:10.14341/omet13261
Tzianabos, C., Chouinard, G., & Martínez, L. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114650
Caprio, M., Cimino, L., Vignera, S. L., & Calogero, A. E. (2022) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-022-01423-5
Self-citation
- Authors
- La Vignera, S., Cannarella, R., Galvano, F., Grillo, A., Aversa, A., Cimino, L., Magagnini, C. M., Mongioì, L. M., Condorelli, R. A., & Calogero, A. E.
- Affiliations
- University of Catania (IT)
- Corresponding author
- Condorelli, Rosita A.
- ORCID
- Venue
- Endocrine
- Published
- 2020-10-15
- Volume
- 72
- Issue
- 2
- Pages
- 392-399
- ISSN
- 0969-711X (ISSN-L)
- 1355-008X
- 1559-0100
- PMC
- PMC8128723
- OpenAlex
- W3093273105
- Cited by
- 36
- References
- 53
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 13 · 2021: 4 · 2020: 1 · 2014: 1
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Endocrine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, University and Research (PRIN 2017XLFJAX)
- Topics
- Health Sciences › Medicine › Physiology › Diet and metabolism studies
- Health Sciences › Medicine › Physiology › Dietary Effects on Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- ketogenic diet, very low-calorie ketogenic diet, testosterone, beta-cell function, proinsulin, proinsulin/insulin ratio, insulin resistance, obesity, overweight men, weight loss, HOMA index, C-peptide, insulin secretion, insulin sensitivity, hyperinsulinemia, hyperandrogenism, male infertility, male hypogonadism
- MeSH terms
- Adult, Humans, Hypogonadism, Male, Middle Aged, Obesity, Body Mass Index, Overweight, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review